Investing in top COVID-19 vaccine maker Pfizer (NYSE: PFE) seems like it should have made you rich if you bought the stock in March 2020. However, you might be surprised with its performance since then. While you would have netted a decent profit, it may not be as much as you expected.

Here's a look at how the stock has done over the past few years, and whether it's a buy right now.

On March 2, 2020, Pfizer's stock was selling for $33 a share. If you had invested $25,000 into the business then, you would have been able to acquire approximately 758 shares of the company. It wouldn't be until nine days later that the World Health Organization would declare a COVID-19 pandemic. It would be nearly a year before Pfizer had an approved COVID-19 vaccine, which was produced in partnership with BioNTech.

Continue reading

Source Fool.com